Search

everythinglearnresearchcommunity

for

Search:↓

High dose rate electronic brachytherapy is an effective and safe non-surgical treatment for nonmelanoma skin cancer with good cosmetic results after three years.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Finasteride's effects on prostate cancer are not clear from this text.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Male pattern baldness may be linked to prostate cancer risk.

Men and women may have different risks of getting skin cancer.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Understanding breast cancer requires considering both medical advancements and social influences.

The hedgehog signalling pathway is key in skin development and basal cell carcinoma, offering insights for prevention and treatment.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Keratin 17 is linked to various diseases, including cancer and skin conditions, and may be a target for diagnosis and treatment.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Vertex pattern hair loss linked to higher prostate cancer risk.

Licorice root-derived nanoparticles target liver cancer cells to improve treatment and reduce side effects.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Xiaoaiping reduces chemotherapy side effects and improves quality of life for breast cancer patients.